Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | CDC25C | P30307 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4520539 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL10465103 | 0.81 | PRNP (0.45) | SMN1; SMN2ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL4526167 | 0.80 | RXFP1 (0.47) | ALDH1A1HPGDMEN1KMT2ARAB9A | |
| SCHEMBL13921790 | 0.78 | NPC1 (0.47) | L3MBTL1RAB9ALMNAKDM4ENPC1 | |
| SCHEMBL28911954 | 0.75 | RXFP1 (0.43) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL17348463 | 0.71 | CYP19A1 (0.46) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL22208244 | 0.71 | MEN1 (0.47) | SMN1; SMN2ALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL22146816 | 0.71 | AKR1C3 (0.61) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL22208242 | 0.71 | MEN1 (0.47) | SMN1; SMN2ALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL277672 | 0.71 | CDC25B (0.82) | ALDH1A1HPGDMEN1KMT2ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| EP-1874740-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006114377-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066231-A1 | Electroluminescent device | CD99, TEC, TYR | SMN1; SMN2 4409/4885ALDH1A1 281/4885HPGD 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.